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Abstract
Schistosome parasites cause schistosomiasis, one of the most prevalent parasitemias worldwide affecting humans and
animals. Constant pairing of schistosomes is essential for female sexual maturation and egg production, which causes
pathogenesis. Female maturation involves signaling pathways controlling mitosis and differentiation within the gonads. In
vitro studies had shown before that a Src-specific inhibitor, Herbimycin A (Herb A), and a TGFb receptor (TbR) inhibitor
(TRIKI) have physiological effects such as suppressed mitoses and egg production in paired females. As one Herb A target,
the gonad-specifically expressed Src kinase SmTK3 was identified. Here, we comparatively analyzed the transcriptome
profiles of Herb A- and TRIKI-treated females identifying transcriptional targets of Src-kinase and TbRI pathways. After
demonstrating that TRIKI inhibits the schistosome TGFbreceptor SmTbRI by kinase assays in Xenopus oocytes, couples were
treated with Herb A, TRIKI, or both inhibitors simultaneously in vitro. RNA was isolated from females for microarray
hybridizations and transcription analyses. The obtained data were evaluated by Gene Ontology (GO) and Ingenuity Pathway
Analysis (IPA), but also by manual classification and intersection analyses. Finally, extensive qPCR experiments were done to
verify differential transcription of candidate genes under inhibitor influence but also to functionally reinforce specific
physiological effects. A number of genes found to be differentially regulated are associated with mitosis and differentiation.
Among these were calcium-associated genes and eggshell-forming genes. In situ hybridization confirmed transcription of
genes coding for the calcium sensor hippocalcin, the calcium transporter ORAI-1, and the calcium-binding protein
calmodulin-4 in the reproductive system pointing to a role of calcium in parasite reproduction. Functional qPCR results
confirmed an inhibitor-influenced, varying dependence of the transcriptional activities of Smp14, Smp48, fs800, a predicted
eggshell precursor protein and SmTYR1. The results show that eggshell-formation is regulated by at least two pathways
cooperatively operating in a balanced manner to control egg production.
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Introduction
Blood-dwelling endoparasites of the genus Schistosoma are the
only trematodes that have evolved a gender dimorphism [1,2].
These parasites cause schistosomiasis, which is of worldwide
significance for humans and animals in tropical and sub-tropical
areas [3]. About 780 million people live in endemic areas being at
risk of schistosomiasis, of which 200 million are infected generating
annual losses of 1.7 to 4.5 million disability adjusted life years
(DALYs) of humans as determined by the Global Burden of
Disease Programme [4,5]. Living in the abdominal veins of their
vertebrate hosts, adult paired females produce up to 300 eggs per
day. Half of these eggs penetrates the epithelia and reach the gut
lumen (e.g. S. mansoni) or the bladder (S. haematobium) to be
transported to the environment for continuing the life cycle. The
remaining eggs migrate via the blood stream to different organs
such as spleen and liver, where they get trapped causing
granuloma formation and liver cirrhosis [6,7].
A unique biological feature of schistosomes is the dependency of
the sexual maturation of the female on a constant pairing contact
with the male. Following pairing, mitoses and differentiation are
induced in the female leading to the differentiation of the
reproductive organs, ovary and vitellarium [8,9]. Regarding the
importance of eggs for continuing the life cycle and provoking
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pathogenesis, a number of studies focused on the identification and
characterization of genes controlling reproductive development of
this parasite [8,10–14]. Furthermore, genome and transcriptome
projects have unravelled the parasite’s genetic repertoire [15–17].
Several members of the TGFb signaling pathway were identified,
which is a highly conserved pathway throughout the animal
kingdom. Among these, the type I TGFb receptor (SmTbRI;
Smp_049760; [18]), a type IIb activin receptor called SmRK2
(SmActRIIb; Smp_144390; [19]), SmSmad4 (Smp_033950; [20]),
SmSmad2 (Smp_085910; [21]), and SmFKBP12 (Smp_079230;
[22]) were identified. Localisation studies revealed a preferential
expression of the listed molecules within the reproductive organs.
SmTbRI transcripts were localised within the vitellarium and
ovary as well as the parenchyma of both genders [23].
Furthermore, expression of SmTbRI protein was also found at
the surface of male parasites [18]. SmActRIIb was found to be
expressed in males and females, and localised on the tegumental
surface of the gynaecophoral canal and some parenchymatic cells
[19]. SmSmad4 was detected within epithelia surrounding the gut
and vitellarium, as well as the subtegument and muscles of males
[20] and SmSmad2 within the vitellarium, the developing egg, and
the ovary of the female worm, but also in the testes and tubercles
of the male [24]. SmFKBP12 co-localised with SmTbRI in the
female gonads as well as the parenchyma of the adult schistosomes
[23].
In the animal kingdom, the TGFb pathway controls prolifer-
ation and differentiation processes [25]. First studies to elucidate
the functional meaning of the schistosome TGFb pathway have
included ligand-induction and inhibitor-suppression approaches
[11,26]. Using human TGFb (hTGFb) to induce the TGFb
pathway in adults in vitro, a recent study showed that genes related
to morphology, development, and cell cycle were differentially
transcribed [27]. Earlier studies, based on the use of a specific
TbRI kinase inhibitor (TRIKI) in adult schistosomes in vitro to
suppress the TGFb pathway, provided first evidence for its role in
regulating mitotic activity and egg production in paired S. mansoni
females [11]. Using a similar inhibitor approach with adults in vitro
indicated the additional influence of (a) Src kinase-containing
pathway(s) on these processes in paired S. mansoni females. Based
on the discovery of the gonad-specific expression of the cellular Src
tyrosine kinase SmTK3 (Smp_151300; [28]), inhibition experi-
ments with the Src-kinase inhibitor Herbimycin A (Herb A) led to
reduced mitotic activity and egg production in paired females as
well [29]. The comparison of both inhibitor treatments pointed to
a stronger reduction of both parameters following Herb A
treatment [11]. The strongest influence on the mitotic activity
and egg production was observed by combining both inhibitors.
In this study, we investigated the inhibitory impact of TRIKI,
Herb A, or the combined compounds on the transcriptome of
female schistosomes using a microarray approach and compre-
hensive qPCR analyses. Besides the identification of a large
number of genes, which were differentially transcribed upon
inhibitor treatment, the results provide strong molecular evidence
for the participation of both TbRI and Src kinase-containing
pathways controlling the transcription of genes involved in eggshell
formation in a cooperative and balanced manner.
Results
Inhibition of SmTbRI kinase by TRIKI
The predicted inhibition of SmTbRI by TRIKI (also known as
LY-364947) was confirmed by expressing the recombinant
intracellular active kinase domain of SmTbRI in Xenopus laevis
oocytes [30], a suitable system for the expression and detection of
kinase activity of schistosome proteins [31–34]. In X. laevis stage VI
oocytes naturally blocked in prophase I of meiosis I, the kinase
potential of an exogenous recombinant active kinase triggers
resumption of meiosis and thus germinal vesicle breakdown
(GVBD), a process easily monitored by the appearance of a
characteristic white spot at the animal pole of the oocyte [30]. To
functionally analyze the kinase potential of SmTbRI, a constitu-
tively active variant (SmTbRI7D) [35] and an inactive one
(SmTbRIVVAAAVV) were generated by site-directed mutagenesis,
and appropriate cRNAs were injected into Xenopus oocytes. Results
shown in Figure 1 demonstrated that expression of the active
SmTbRI7D version induced GVBD in $80% of oocytes whereas
the inactive one SmTbRIVVAAAVV had no effect on the fate of the
oocytes. In the presence of TRIKI, oocytes expressing SmTbRI7D
underwent no more GVBD when drug concentrations $30 nM
were used, confirming the inhibitory effect of TRIKI on SmTbRI
kinase. For comparison, previous experiments showed that in this
cellular system a complete inhibition of the Src kinase SmTK3 was
obtained using 10 nM Herb A [34]. GVBD induced in control
oocytes by the natural stimulus progesterone [30] was not affected
by TRIKI-treatment (data not shown), demonstrating a specific
effect of TRIKI on the SmTbRI kinase in injected oocytes.
Transcriptome analyses of inhibitor-treated adults by
microarrays
Based on previous findings of reduced mitotic activity and egg
production following inhibitor treatment of adult female schisto-
somes in vitro [11,29], we devised an approach to unravel the
molecular mechanisms affected by these inhibitors. To this end,
large-scale transcriptional analyses were performed using a
microarray platform representing nearly the complete S. mansoni
transcriptome [27,36,37]. Our experimental design comprised
adult schistosomes that were cultured in vitro for 48 h with either
TRIKI (300 nM), Herb A (4.5 mM), the combination of both
inhibitors (H+T), or with DMSO only as control.
Author Summary
As one of the most prevalent parasitic infections world-
wide, schistosomiasis is caused by blood-flukes of the
genus Schistosoma. Pathology coincides with egg produc-
tion, which is started upon pairing of the dioeciously living
adults. A constant pairing contact is required to induce
mitoses and differentiation processes in the female leading
to the development of the gonads. Although long known,
the molecular processes controlling gonad development
or egg-production in schistosomes or other platyhelminths
are largely unknown. Using an established in vitro-culture
system and specific, chemical inhibitors we have obtained
first evidence in previous studies for the participation of
signal transduction processes playing essential roles in
controlling mitoses, differentiation and egg production. In
the present study we applied combinatory inhibitor
treatments combined with subsequent microarray and
qPCR analyses and demonstrate for the first time that
cooperating Src-Kinase- und TGFb-signaling pathways
control mitoses and egg formation processes. Besides
direct evidence for managing transcription of eggshell-
forming genes, new target molecules of these pathways
were identified. Among these are calcium-associated
genes providing a first hint towards a role of this ion for
reproduction. Our finding shed first light on the signaling
mechanisms controlling egg formation, which is important
for life-cycling and pathology.
Src- and TGFb-pathway Cooperation in S. mansoni
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Identification of genes differentially transcribed following
TRIKI-treatment
A total number of 8745 genes were detected as expressed in the
TRIKI-treatment assays. According to subsequent significance
analysis of the microarray data (SAM, q-value#0.03) 2595 genes
were found to be differentially transcribed when compared to the
control. Of these, 2330 were protein-coding genes, while 265 had
an antisense-orientation relative to the protein-coding gene in the
given locus (Supplementary Table S1). A hierarchical clustering of
the replicate data was performed (Fig. 2A), showing that the
transcription of 1765 protein-coding genes was enhanced (up-
regulated, red), and of 565 repressed (down-regulated, green). The
opposite tendency was detected for antisense transcripts, where 67
showed enhanced, and 198 repressed transcription. A list with all
differentially transcribed genes is available in Supplementary
Table S2. Further functional analyses were done only with
protein-coding genes.
GO analyses of differentially transcribed genes revealed
ontology categories enriched with genes being up- or down-
regulated (BH adjusted p-value#0.05; Supplementary Table S3).
The GO category ncRNA metabolic process belonged to the
ontology biological process, and contained genes with enhanced
transcription. For genes with repressed transcription the ontologies
biological process, including the category mRNA metabolic
process, and cellular component were detected.
Using IPA, a number of networks enriched with proteins coded
by differentially transcribed genes were identified, of which the five
most significant are presented (summarised in Supplementary
Table S4). The first network included molecules involved in gene
expression, protein synthesis, and amino acid metabolism. The
second network contained molecules necessary for small molecule
biochemistry, lipid metabolism, and amino acid metabolism.
Molecules of the third network were associated with cell cycle,
cellular function and maintenance, and molecular transport. The
fourth network included molecules of nucleic acid metabolism,
small molecule biochemistry and DNA replication, recombination
and repair. The fifth network consisted of molecules belonging to
lipid metabolism, nucleic acid metabolism, and small molecule
biochemistry.
Identification of genes differentially transcribed following
Herb A-treatment
A total number of 8016 genes were detected as expressed in the
Herb A-treatment assays. SAM identified 1181 genes to be
differentially transcribed with a q-value#0.03. Among these, 1021
represented protein-coding genes and 160 antisense-oriented
transcripts (Supplementary Table S5). A hierarchical clustering
of the protein-coding genes was performed (Fig. 2B), showing that
a majority of 719 genes had an enhanced transcription, whereas
302 exhibited a repressed transcription. The opposite pattern was
found for the antisense-oriented genes. Here, 57 genes were
enhanced in their transcription and 103 genes repressed (see also
Supplementary Table S1). Further functional analyses were done
only with probes representing protein-coding genes.
GO analysis resulted in the identification of GO categories (BH
adjusted p-value of #0.05) significantly enriched only with genes
showing enhanced transcription (Supplementary Table S6). The
identified categories of the ontology biological process were
negative regulation of molecular function, cellular carbohydrate
metabolic process, protein folding, and glycoprotein metabolic
process. The categories belonging to the ontology molecular
function were peptidase regulator activity, enzyme inhibitor
Figure 1. Inhibition of SmTbRI activity by TRIKI. Inhibitory effect of TRIKI on SmTbRI kinase activity was monitored in Xenopus laevis oocytes
expressing the intracellular domain of SmTbRI by measuring the level of GVBD induced by the kinase in the oocytes. Results of GVBD assays
performed in TRIKI-treated oocytes (used concentrations: 0 nM, 3 nM, 30 nM, 300 nM), which expressed either the constitutively active intracellular
part of SmTbRI (SmTbRI7D; the experiments were performed twice: 1u, dark grey squares; 2u, light grey rhombs), or an inactive kinase variant
(SmTbRIVVAAAVV, black circles) as control.
doi:10.1371/journal.ppat.1003448.g001
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Figure 2. Hierarchical clustering of differentially transcribed genes (q#0.03) following TRIKI-treatment, Herbimycin A-treatment,
and combined inhibitor treatment. Hierarchical clustering of (A) 2330 (TRIKI), (B) 1021 (Herbimycin A), and (C) 411 (combined inhibitors)
differentially transcribed genes (q#0.03) of treated and control female schistosomes. Columns represent three biological replicas as well as two
Src- and TGFb-pathway Cooperation in S. mansoni
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activity, and peptidase inhibitor activity. The cellular component
ontology included genes belonging to the categories nuclear
membrane-endoplasmic reticulum network and endoplasmic
reticulum membrane.
Among the five networks detected by IPA as most significantly
enriched with proteins coded by genes with altered transcription,
network 1 was comprised of molecules related to post-translational
modification, protein folding, and molecules known from humans
to be involved in cancer (among other signal transduction
proteins). The second network included molecules, whose func-
tions are associated in humans with cancer, gastrointestinal
disease, and genetic disorder.
For the third network molecules involved in RNA post-
transcriptional modification, DNA replication, recombination,
and repair and energy production were enriched (Supplementary
Figure S1A). The fourth network contained molecules involved in
endocrine system development and function, small molecule
biochemistry as well as cellular function and maintenance. The
fifth network comprised molecules involved in carbohydrate
metabolism, cellular function and maintenance, and molecular
transport (Supplementary Table S7).
Identification of genes differentially transcribed following
combined Herb A/TRIKI (H+T) treatment
A total number of 11,668 genes were detected as expressed in
schistosome parasites in the assays with Herbimycin A and
TRIKI. Using SAM statistics, 521 genes were identified as
differentially transcribed with a q-value of #0.03 (Supplementary
Table S8). From these, 411 were protein-coding genes and 110
antisense-oriented transcripts, respectively (Supplementary Table
S1). A hierarchical clustering was performed (Fig. 2C), and showed
that a higher number of protein-coding genes had an enhanced
transcription (254) compared to those with repressed (157)
transcription. The same picture was obtained for the antisense
messages. Among these, 70 genes showed an enhanced transcrip-
tion, 40 a repressed transcription upon the combined inhibitor
treatment. Further functional analyses were conducted only with
protein-coding genes.
By GO analyses a significant enrichment (BH adjusted p-
value#0.05) of genes with an enhanced, as well as repressed
transcription was identified for different GO categories (Supple-
mentary Table S9). In summary, enriched genes with enhanced
transcription were part of GO categories including multicellular
organismal process, localisation of cell, nucleobase, nucleoside,
nucleotide and nucleic acid transport, RNA localisation, metabolic
process, regulation of cellular metabolic process, regulation of
biosynthesis, and cellular nitrogen compound metabolic process
(including the corresponding subcategories) for the ontology
biological process. The identified categories (and corresponding
subcategories) of the ontology molecular function were: hydrolase
activity, acting on acid anhydrides, structural molecule activity,
binding, and calmodulin binding. Categories comprised of genes
showing repressed transcription following the combined inhibitor-
treatment included ion binding and peptidase activity, for the
ontology molecular function. The ontology biological process
included the categories membrane lipid biosynthetic process,
protein modification process, and melanin biosynthetic process.
Using IPA, two networks with significantly enriched proteins
coded by differentially transcribed genes were identified. The first
included molecules associated with post-translational modification,
protein folding and cellular comprise. The second network
comprised cellular function and maintenance, nucleic acid
metabolism, and small molecule biochemistry (Supplementary
Table S10).
Comparative analyses of differentially transcribed genes
identified following inhibitor treatments
To get an overview of genes that were influenced by at least one
inhibitor treatment, a data comparison was performed analysing
the overlapping differentially transcribed protein-coding genes
(q#0.03) and a Venn diagram was created (Fig. 3; Supplementary
Table S11).
Transcription of a large number of genes was affected by one
treatment only. 1933 genes were exclusively found to be regulated
by TRIKI, while the transcription of 659 genes was influenced by
Herb A, and the transcription of 238 genes was affected by the
combined treatment only. Regulation of 302 genes was affected by
TRIKI as well as Herb A, but these genes were not detected as
technical replicas (A, TRIKI: columns TRIKI/DMSO 6 and 5, as well as TRIKI/DMSO 1 and 2 represent technical replicas of the first two biological replicas,
respectively; TRIKI/DMSO 3 represents the 3rd biological replicate. B, Herbimycin A: columns Herb/DMSO 2 and 1, as well as Herb/DMSO 5 and 6
represent technical replicas of the first two biological replicas, respectively; Herb/DMSO 3 the 3rd biological replicate. C, combined inhibitors: columns
H+T/DMSO 6 and 5, as well as H+T/DMSO 4 and 3 represent technical replicas of the first two biological replicas, respectively; H+T/DMSO 2 represents
the 3rd biological replicate). Each line shows the calculated log2ratio (treated/control) of the transcription of a gene; genes with a repressed
transcription were colored in green (A, TRIKI: 565 genes; B, Herbimycin A: 302 genes; C, combined inhibitors: 157 genes) and genes with an enhanced
transcription in red (A, TRIKI: 1765 genes; B, Herbimycin A: 719 genes; C, combined inhibitors: 254 genes).
doi:10.1371/journal.ppat.1003448.g002
Figure 3. Venn diagram of differentially transcribed genes
identified by different inhibitor treatments. Numbers of differ-
entially transcribed protein-coding genes of all three microarray
experiments (‘‘TRIKI’’, ‘‘Herbimycin A’’, ‘‘Combined treatment’’). Each
circle represents the microarray result of one of the inhibitor
treatments. The intersections show the numbers of corresponding
genes differentially transcribed following treatment with different
inhibitors.
doi:10.1371/journal.ppat.1003448.g003
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differentially transcribed in the data set from the combined
approach. Of these, 87% were transcriptionally regulated in the
same direction (213 genes were up- and 50 down-regulated in each
of the two treatments), and 13% in inverse directions (18 genes
were down-regulated and 21 up-regulated by Herb A treatment,
with an opposite pattern in TRIKI treated worms). 113 genes were
affected in their transcription by TRIKI or the combined
treatment, of which only 32% were equally regulated (34 genes
were up- and 2 genes down-regulated in either condition), and
68% of these genes were inversely regulated (13 genes were up-
and 64 down-regulated by the combined treatment and showed an
opposite change upon treatment with TRIKI alone).
Treatment of worms with Herb A or the combined inhibitors
resulted in the differential transcription of 78 genes. In contrast to
the proportions of genes whose transcription was influenced by
TRIKI-treatment or the combined inhibitors, here 72% were
regulated in the same direction (46 genes were up- and 10 genes
down-regulated in either condition), and 28% had an inverse
pattern (21 genes were up- and 1 gene was down-regulated by the
combined treatment and showed an opposite change upon Herb A
treatment alone).
The intersection of all three experiments comprised 18 genes,
which included e.g. an hsp70-interacting protein, an immunophil-
in homolog, different hypothetical proteins, and calmodulin-4.
Validation of selected differentially transcribed genes by
quantitative PCR experiments
GO, IPA, and literature-based research were the basis of the
selection of differentially transcribed genes, whose inhibitor-
influenced transcription was validated by qPCR. Additionally, a
manual classification of differentially transcribed genes was used
for selecting further candidates.
A huge number of signaling molecules were identified to be
affected by at least one inhibitor treatment. Among these were
several members of the schistosome TGFb pathway [12,21,38].
Thus two TGFb superfamily receptors, e.g. SmTbRI
(Smp_049760), as well as SmActRIIb (Smp_144390) were
transcriptionally enhanced, whereas SmSmad4 (Smp_033950)
showed a repressed transcription following TRIKI-treatment.
SmActRIIb and SmSmad 4 were transcriptionally regulated in the
same direction following Herb A-treatment.
Also genes involved in eggshell formation were found to be
influenced by all inhibitor approaches. Selected candidates were
the predicted eggshell precursor protein (Smp_000430) and an
eggshell protein similar to fs800 (Smp_000270) [39]. Both showed
enhanced transcription following TRIKI-treatment, which was
unexpected due to the slight negative effect of TRIKI on egg
production of female schistosomes shown before [11]. In contrast
to this result, the combined treatment led to a repressed
transcription for both genes, which was expected according to
the strong reduction of the egg production following this dual
inhibitor approach [11]. As another eggshell gene Smp48
(Smp_014610) [40] was chosen, whose transcription was repressed
following the Herb A-treatment. This inhibitor was shown before
to negatively influence egg production of treated couples in vitro
[11,29]. Finally, tyrosinase 1 (SmTYR1, Smp_050270) was
selected, a gene which was localised in the vitellarium and shown
to be responsible for cross-linking processes of eggshell precursor
proteins [41]. SmTYR1 was transcriptionally repressed following
the combined inhibitory treatment.
As a candidate for surface proteins tetraspanin 18
(Smp_174190) was chosen due to the strongest repressed
transcription among the regulated tetraspanins according to
TRIKI data analysis. Another member of this protein class was
tetraspanin-1 (Smp_011560), which showed the same transcription
tendency following Herb A-treatment. Furthermore, the combined
inhibitor treatment revealed another tetraspanin 1 homolog
(Smp_155310.1) to be transcriptionally repressed. This molecule
was also detected within the GO categories membrane and
membrane parts. The mentioned tetraspanin homologs have not
been characterized in schistosomes yet.
Many heat shock protein genes were identified within the data
sets of the individual Herb A- and the combined treatment.
Among these was a hsp70 homolog (Smp_106930), which we
selected as a representative of transcriptionally enhanced hsps
following both inhibitor treatments. Furthermore, IPA of the data
sets of both treatments identified hsp70 within network 1, which
includes molecules involved in protein folding, in each case. An
impact of Herb A on protein folding processes was shown
previously to result in the transcriptional activation of hsp70 [42].
Other molecules identified by IPA were the sodium/potassium-
pump (Na/K-pump; Smp_015020) and cathepsin S
(Smp_139240). As a member of network 3 the Na/K-pump was
detected with an enhanced transcription following TRIKI-
treatment. Cathepsin S showed a repressed transcription following
the combined inhibitor treatment, and it belonged to the network
1. Further candidates were small nuclear ribonucleoprotein (snurp;
Smp_069880), which we identified within the GO category
‘‘mRNA metabolic process’’, and within the IPA network 2 of
TRIKI data analysis.
As a representative gene, whose transcription was affected by all
three inhibitor treatments, calmodulin-4 (Smp_032990) was
selected for validation. It was additionally identified within the
category binding of the GO analysis of the combined treatment
data set.
For the validation of the microarray data following TRIKI-
treatment the genes coding for SmTbRI, SmActRIIb, a protein
similar to fs800, a predicted eggshell precursor protein, and Na/
K-pump were finally selected as candidates for enhanced
transcription (Fig. 4A). Calmodulin-4, tetraspanin 18, SmSmad
4, and a snurp were chosen as representatives of transcriptionally
repressed genes (Fig. 4B). In contrast to SmTbRI, SmActRIIb,
Na/K-pump, and snurp the results of qPCR and microarray
analyses correlated well for all other genes. The different results of
the qPCR of both receptors, the Na/K pump, and snurp may be
explained by biological variance between worm batches and/or by
cross-hybridization. Contradictory results of qPCR and micro-
array for a small fraction of false-positive genes have already been
documented in the literature [43]. Because of the high standard
deviations of the microarray log2ratio-values, the contradictory
results of qPCR and microarray for the Na/K-pump suggested
that this gene might belong to the false-positive genes predicted by
SAM. Due to the biological variance of the used worm batches,
the calculated correlation coefficient according to Spearman was
not significant comparing all qPCRs and the corresponding
microarray data directly.
For the validation of the microarray data following Herb A-
treatment the genes coding for SmActRIIb, calmodulin-4 and
hsp70 were chosen as representatives for enhanced transcription
(Fig. 5A). Tetraspanin-1, SmSmad4 and Smp48 showed a
repressed transcription in the microarray data (Fig. 5B). The
results of both analyses correlated well for calmodulin-4, hsp70,
tetraspanin-1, SmSmad 4 and Smp48. The qPCR result obtained
for SmActRIIb was contradictory to that of the microarray, which
may have resulted from biological variations of the used worm
batches. Nevertheless, the results obtained for these genes with
both analyses significant correlated according to Spearman’s
Correlations Coefficient (rs = 0.886).
Src- and TGFb-pathway Cooperation in S. mansoni
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The validation of the microarray data of females treated with
both inhibitors included the transcriptionally enhanced genes
calmodulin-4 and hsp70 (see Fig. 6A). A repressed transcription
was detected for the genes coding for a protein similar to fs800, the
eggshell precursor protein, tetraspanin 1, SmTYR1 and cathepsin
S (Fig. 6B). An increase of transcript levels was confirmed for
calmodulin-4 and for hsp70, at least in one qPCR experiment.
The identified reduction of transcripts was confirmed for
Figure 4. Comparison of qPCR and microarray results following TRIKI-treatment. Transcriptional changes from the TRIKI-treatment of
adult schistosome females detected in qPCR and microarray data were calculated as log2ratios (treated/control). The investigated genes were
SmTbRI, SmActRIIb, a protein similar to fs800, eggshell precursor, and Na/K-pump as representative for enhanced transcription within the microarray
data set (A). The selected genes representing the set of genes with repressed transcription within the microarray data set (B) were calmodulin-4,
tetraspanin 18, SmSmad 4, and snurp. For each method three biological replicas were used, each with two technical replicas for the microarray
analysis (except microarray 2) and three technical replicas for the qPCR. The mean of the technical replicas was calculated and is presented with
standard deviations.
doi:10.1371/journal.ppat.1003448.g004
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tetraspanin 1, SmTYR1, and cathepsin S. For the gene similar to
fs800 an increased transcript level was shown for two biological
replicas by qPCR, but for the third qPCR replica and the
microarray data a reduction of transcripts was determined. Both
results correlated significantly according to Spearman’s Correla-
tions Coefficient (rs = 0.7234).
Figure 5. Comparison of qPCR and microarray results following Herbimycin A-treatment. Transcriptional changes from the Herb A-
treatment of adult schistosome females detected in qPCR and microarray data were calculated as log2ratios (treated/control). According to the
microarray analysis SmActRIIb, calmodulin-4, and hsp70 showed enhanced transcription (A), whereas tetraspanin-1, SmSmad 4, and Smp48 were
detected as transcriptionally repressed (B). For each method three biological replicas were used, each with two technical replicas for the microarray
analysis (except microarray 2) and three technical replicas for the qPCR. The mean of the technical replicas was calculated and is presented with
standard deviations.
doi:10.1371/journal.ppat.1003448.g005
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Transcriptional analyses of selected genes involved in
eggshell-formation following inhibitor treatments
During the study we obtained multiple evidence for inhibitor-
induced differential transcription of different genes with known
function in eggshell formation. In light of this and of previous
evidence of a strong negative effect of Herb A as well as a
moderate negative effect of TRIKI on egg production [11],
functional qPCR experiments were performed focusing on the
analysis of a variety of candidates for protein-coding genes
Figure 6. Comparison of qPCR and microarray results following the combined inhibitor treatment. Transcriptional changes from the
simultaneous TRIKI- and Herb A-treatment of adult schistosome females detected in qPCR and microarray data were calculated as log2ratios (treated/
control). The investigated genes with enhanced transcription, as determined by microarray analysis, were calmodulin-4 and hsp70 (A), the genes with
repressed transcription comprised a gene similar to fs800, an eggshell precursor protein, tetraspanin 1, SmTYR1, and cathepsin S (B). For each method
three biological replicas were used, each with two technical replicas for the microarray analysis (except microarray 2) and three technical replicas for
the qPCR. The mean of the technical replicas was calculated and is presented with standard deviations.
doi:10.1371/journal.ppat.1003448.g006
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involved in this decisive step of the schistosome life cycle. The
selected genes were the two well-characterized eggshell precursor
protein Smp14 (Smp_131110.x; [44]) and Smp48 (Smp_014610;
[40]) as well as a predicted eggshell precursor protein
(Smp_000430), which is still uncharacterized. Furthermore, we
included the eggshell protein cross-linker SmTYR1 (Smp_050270;
[41]) and the eggshell component, which was identified as similar
to fs800 (Smp_000270; [39]) into this analysis. Towards this end
paired female schistosomes were cultured in vitro under the same
conditions as before for the microarray approaches to obtain a
comparable basis for the transcriptional analyses. For this analysis
the microarray data were used independent of their significance
values.
All three inhibitor treatments influenced the transcription of all
genes selected (Fig. 7). In the majority of cases TRIKI-treatment
resulted in an increase of transcript levels, which corresponded to
the available microarray data. Due to the filtering criteria, the
microarray data for Smp14 and Smp48 were not present within
the microarray data sets although representative oligonucleotide
probes existed. In contrast, SmTYR1 passed filtering during
microarray data processing, but the transcriptional changes were
not detected to be significant. Significant transcriptional changes
were observed by microarrays for the gene similar to fs800 and the
eggshell precursor protein following TRIKI-treatment.
For Herb A-treated worms, a reduction of the transcripts of all
genes was found by qPCR and this effect was stronger, when
compared with the transcriptional changes of the combined
inhibitor treatment. Furthermore, the reduced transcription of the
qPCR-validated genes in Herb A-treated worms was in accor-
dance with the findings of the microarray analysis. Here a
repressed transcription was also determined for Smp14, the
eggshell precursor protein, and at least for two biological replicas
for SmTYR1 and the protein similar to fs800. The repressed
transcription of Smp48 was the only significant transcriptional
change within the microarray analysis, although the second replica
showed a log2ratio of nearly 0.
The combined treatment, finally, led to a repressed transcrip-
tion of all genes in both analyses, except two biological replicas
used for the qPCR analysis for the fs800 gene. Although the
tendency of down-regulation of the transcription of the selected
genes corresponded well with the results obtained for Herb A-
treated females, the effect of the combined treatment was found to
be not as strong. Here, the detected decrease of transcripts was
significant for the eggshell precursor protein, SmTYR1 and the
gene similar to fs800 in the microarray analysis.
In summary, the results confirmed a strong influence of the used
inhibitors on transcriptional regulation of chosen genes involved in
eggshell-formation processes. Furthermore, the data demonstrated
a stronger effect of Herb A compared to TRIKI, which was in
accordance with the observation of the physiological effects
reported before [11]. Thus the results of our study provide the
first molecular evidence that transcriptional regulation of genes
involved in eggshell-formation processes is under the control of
Src- and TbRI-containing signaling pathways.
Figure 7. Comparison of qPCR and microarray results of genes involved in eggshell-formation processes. Summary of the log2ratio
(treated/control) obtained by qPCR and microarray analyses of genes coding for proteins proven or hypothesised to be involved eggshell-formation
processes following treatment of paired female schistosomes with either 300 nM TRIKI, 4.5 mM Herb A, or the combination of both inhibitors. The
investigated genes were the eggshell precursor proteins Smp14 and Smp48 as well as a predicted eggshell precursor protein (precursor), the
tyrosinase 1 (SmTYR1), and a gene similar to fs800. For each method three biological replicas were used, each with two technical replicas for the
microarray analysis (except microarray 2) and three technical replicas for the qPCR. The mean of the technical replicas was calculated and is presented
with standard deviations.
doi:10.1371/journal.ppat.1003448.g007
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Calcium-associated genes are transcribed in the
reproductive system
One additional finding of this study was that a number of genes
with predicted calcium-associated functions were among those
found to be differentially regulated (see also Supplementary Figure
S1B). To provide evidence for their potential contribution to egg
production processes we performed localization studies investigat-
ing the tissue-specific transcription of candidate genes (Fig. 8). By
in situ hybridization experiments, transcripts of hippocalcin, a
neuronal calcium sensor [45,46], were detected within the ovary,
in the vitellarium and around the ootype (Fig. 8 A, B), where
according to classical literature the Mehlis’ gland is located [47–
49]. Transcripts of the potential calcium-influx channel protein
ORAI-1 [50] were found to be expressed in ovary and vitellarium
of the female and testes of the male (Fig. 8 D, E). Transcripts of the
predicted eggshell precursor protein gene were detected within the
vitellarium (Fig. 8 G). This was expected with respect to previous
findings of the expression of similar genes such as p14 [44], which
was used in our study as positive control (data not shown).
Additionally, signals of the predicted eggshell precursor protein
gene were also observed in the ovary (Fig. 8 H), which was
unexpected with regard to p14 that is predominately expressed in
the vitellarium. Finally, calmodulin-4 transcripts were observed
within the vitelloduct and around the ootype (Fig. 8 J). In this case,
the gene prediction indicated a small gene with the consequence
that the probe used was relatively short compared to others
normally used for this technique. Thus we cannot exclude being
close to the detection limit in this case and that calmodulin-4 may
be also transcribed in other organs. Furthermore, evidence for the
presence of antisense transcripts of hippocalcin (Fig. 8 C) and
calmodulin-4 (Fig. 8 L) was found since signals were obtained with
sense RNAs in the same tissues. To confirm these transcription
patterns, organ-specific RT-PCRs were performed (Supplementa-
ry Figure S2) with template RNA of purified testes and ovaries
obtained by a novel method for the isolation and enrichment of
ovaries and testes [Hahnel et al., submitted]. The results obtained
confirmed and complemented the in situ findings providing
additional evidence for two splice forms of ORAI-1 in testes and
ovaries as well as calmodulin-4 transcription in testes.
Discussion
Inhibitor experiments in previous studies and in this study have
indicated that Src kinase- and TbRI-containing pathways
influence mitotic activity and egg production in paired schistosome
females [11,29], and that SmTK3 [29,34] and SmTbRI are
targets of Herb A or TRIKI, respectively. Furthermore, a yeast-
two-hybrid (Y2H) cDNA-library screening and subsequent qual-
itative and quantitative analyses identifying and characterizing
binding partners acting ‘‘downstream’’ of SmTK3 detected
besides others a homolog of the BAF60 subunit of the SWI/
SNF complex (SmBAF60) and a diaphanous homolog (SmDia) as
the strongest interacting partners [51]. The SWI/SNF complex is
involved in chromatin-remodeling activities, DNA-damage re-
sponses, transcriptional activation, sliding of nucleosomes, and
alteration of histone-DNA contacts [52]. Diaphanous proteins
belong to the big group of formin-homology proteins known to
play roles in actin-mediated processes controlling cell and tissue
architecture, cell-cell interactions, gastrulation, and cytokinesis
[53].
To detect genes being controlled by SmTK3- and SmTbRI-
containing pathways, presumably playing roles for reproductive
processes in adult schistosomes, microarray analyses were
performed with RNA of inhibitor-treated paired females as
template. A number of genes were detected to be differentially
transcribed by individual inhibitors as well as their combination.
Among these was a minor amount of antisense RNAs. Besides the
possibility that some of these could have protein-coding function,
the majority of these RNAs belong to the big group of non-coding
RNAs (ncRNAs), and their detection, especially during transcrip-
tome analyzes, has opened a new research field since evidence has
accumulated that ncRNAs may have regulatory functions [54].
After first evidence for the occurrence of antisense RNAs in the S.
mansoni genome was obtained [36], a recently performed detailed
analysis estimated that around $10% of the transcribed genome
may represent non-coding RNAs [37]. According to comparative
life-stage analyses, differences in the transcription of schistosome
ncRNAs were found indicating their potential roles in diverse
biological and physiological processes. Thus it was no surprise to
find a fraction of antisense RNAs also in our analysis as being
differentially transcribed following treatment with individual or
both inhibitors. Among these, some may interfere with regulatory
processes. As soon as more knowledge about this class of molecules
exists in schistosomes, the findings of our studies may contribute in
the future to unravel their function.
The highest number of differentially transcribed genes with
protein-coding function was detected for treatment with TRIKI
compared to the other treatments. The same tendency was
observed when intersections were generated between single
treatments and combined treatment, again more genes were
found to be differentially transcribed when TRIKI was used.
Within the intersection of the individual inhibitor treatments (302
genes; Fig. 3), the majority of differentially transcribed genes were
regulated in the same direction, a smaller part in the opposite
direction. This indicates that genes within this intersection may be
targets of both signaling pathways, which were previously
hypothesised to cooperate during cell division and egg production
processes [11]. The identity of genes found within this intersection
indirectly support this assumption since genes well known for their
role in mitosis such as e.g. the cell cycle check point protein rad 17,
cyclin 1, or glypican (Supplementary Table S11) were found.
Unexpectedly, these genes were all found to be up-regulated by
each inhibitor; this was not expected due to the previously
observed inhibitory effect of Herb A and TRIKI on mitotic
activity [11]. However, other genes contributing to mitosis
regulation may have been negatively affected. Indeed, among
the genes down-regulated by each inhibitor is a dynactin homolog
(Supplementary Table S11). Dynactin is known to direct and
coordinate the activities of the dynein motor, which is required for
several cellular functions including cell division [55]. Indirect
support for these conclusions comes from recent laser-microdis-
section microscopy (LMM) and oligonucleotide microarray
analysis, which detected genes up-regulated two-fold or more in
the gastrodermis, the ovary, the vitellarium, and the testes in S.
mansoni and S. japonicum [56,57]. Among these were rad 17 (ovary,
vitellarium), cyclin 1 (ovary), glypican (ovary), and dynactin (ovary,
vitellarium) as representatives of genes with elevated transcript
levels indicating their functional relevance within the gonads.
Furthermore, an IPA analysis of the combined inhibitor
treatment predicted that the c-myc protein might have been
activated, since genes theoretically regulated by c-myc were
differentially transcribed. Along the same line IPA predicted the
protein p53 to be inhibited following Herb A treatment. Since c-
myc is able to cause proliferation inhibition (mitoinhibition; [58])
its putative activation may have contributed to the previously
observed reduction of mitotic activity following treatment with
these inhibitors. Moreover, c-myc expression and p53 inactivation
were described as two cell-cycle events regulated by Src during
Src- and TGFb-pathway Cooperation in S. mansoni
PLOS Pathogens | www.plospathogens.org 11 June 2013 | Volume 9 | Issue 6 | e1003448
Src- and TGFb-pathway Cooperation in S. mansoni
PLOS Pathogens | www.plospathogens.org 12 June 2013 | Volume 9 | Issue 6 | e1003448
mitosis [59]. Detailed clarifications of these points will be the
subject of further studies.
Interestingly, a homolog of Bcl2-associated athanogene (BAG1)
was discovered as being up-regulated by each single inhibitor
treatment. BAG1 binds to Bcl2, an oncogene inhibiting apoptosis,
enhancing its anti-apoptotic effect. In this way BAG1 connects
growth factor receptors with anti-apoptotic mechanisms [60].
Indeed, a recent publication provided first evidence that the
proliferation of vitelline cells is independent of pairing, but their
survival is male-dependent, being pairing-dependently controlled
via apoptosis regulation [61], and LMM-microarray analysis
showed enhanced Bcl2 transcript-levels in the ovary and the
vitellarium [57]. Furthermore, it is noteworthy that a number of
genes involved in calcium regulation were differentially regulated
such as homologs of hippocalcin [45,46,62,63], different calmod-
ulins [55], or the calcium-influx channel protein ORAI-1 [50]. To
provide further evidence for their role in reproduction localization
studies were performed demonstrating that the schistosome
homologs of hippocalcin, ORAI-1, the predicted eggshell precur-
sor protein gene and calmodulin-4 were transcribed within the
reproductive system. Hippocalcin belongs to the calmodulin
superfamily and exerts putative sAHP (slow afterhyperpolariza-
tion) function in the brain of higher eukaryotes [46]. To our
knowledge, there is no information available yet about homologs
in invertebrates. Its particular transcription pattern in schistosomes
indicates a function of hippocalcin in the ovary, the vitellarium,
and within the Mehlis’ gland which is known to contribute to egg
formation [49]. Since in trematodes Mehlis’ glands are connected
to the nervous system as shown by the expression of neuropeptides
within these glands in S. mansoni as well as Fasciola hepatica [64,65],
it is tempting to speculate that schistosome hippocalcin may
among further functions represent another neuronal player
contributing to neurophysiological processes during egg formation.
A neurophysiological function was also shown for the calcium
channel protein ORAI-1 of D. melanogaster, which is required for
normal flight and associated patterns of rhythmic firing of the
flight motoneurons [66]. In C. elegans ORAI-1 knockdown caused
complete sterility confirming its essential role in calcium signaling
in the gonads [67]. With respect to the localization data obtained
in our study, this may apply also to schistosome ORAI-1.
Especially interesting was a calmodulin-4 homolog, which was
(i) present in the GO enrichment analysis of Herb A/TRIKI
double-treated worms, (ii) a member of the group of 18 genes
representing differentially expressed transcripts detected by all
three inhibitor approaches, and (iii) seemed to be a target of both
pathways being up-regulated following Herb A treatment and
down-regulated following TRIKI-treatment as confirmed by our
qPCR results (see Figs. 4–6). Links of both pathways to calcium
mobilisation and signaling exist. Besides its role as a regulator of
the type I TGFb receptors, the immunophilin FKBP12 regulates
the functional state of calcium channel receptors by altering their
conformation and coordinating multi-protein complex formation
[68]. Among others, Src-kinase signaling can lead to calcium
mobilisation contributing to oocyte maturation and fertilisation
[69,70]. A yet uncharacterized immunophilin was also among the
18 differentially transcribed genes identified by all three inhibitor
approaches. Although not in each case (ORAI1, no observed up-
regulation in the gonads), the above mentioned LMM analysis
revealed Ca2+-metabolism-associated genes such as hippocalcin
(ovary, vitellarium) as transcriptionally enhanced [57]. This and
the findings from our study suggest that calcium may also
contribute to the physiological processes controlling egg produc-
tion.
Besides the major intersection of the individual inhibitor
treatments, the other intersections between the combined treat-
ment and the individual treatments revealed further groups of
genes (113/78; Fig. 3) being representatives of potential targets
affected by either TGFb (113; Fig. 3) or Src pathways (78; Fig. 3).
This indicates that one pathway may have a more dominant effect.
With few exceptions such as an (yet uncharacterized) eggshell
precursor protein within the TRIKI/combined treatment inter-
section (113; Fig. 3), the majority of both intersections represented
hypothetical proteins from S. mansoni (Supplementary Table S11),
which may be novel, schistosome-specific targets of these
pathways. The tendencies of transcriptional regulations between
these two groups (113/78) were inversely correlated (group 113:
32%/68% regulated in the same/opposite direction, respectively;
group 78: 72%/28% regulated in the same/opposite direction,
respectively). We interpret this as another evidence for a stronger
response to the inhibition of the Src-kinase containing pathway(s).
A closer look on differentially transcribed genes following
TRIKI-treatment revealed a lot of signaling molecules, which
included members of the schistosome TGFb pathway. All type I
receptors of TGFb superfamily were up-regulated by treatment
with TRIKI, although only SmTbRI and SmBMPRI were
significant for these data, in contrast to the SmActRI. Neverthe-
less, all three type I receptors showed enhanced transcription,
which suggests feedback regulation. This is indirectly supported by
the opposite regulation of follistatin, a regulator of TGFb signaling
[25]. It is part of the major overlap of the single inhibitor
treatments, being up-regulated by TRIKI and down-regulated by
Herb A (302; Fig. 3, Supplementary table S11). Beyond that
SmSmad2 and SmSmad4 showed repressed transcription follow-
ing individual TRIKI or Herb A treatments. The qPCR results
indicated some additional influence by biological variability
among the worm batches used affecting at least SmTbRI and
SmActRI transcription, for which in one of three cases each the
same regulatory tendency, as detected in the microarray data, was
confirmed. LMM-microarray analysis showed enhanced transcript
levels for SmSmad4 (ovary), but not for SmTbRI [56].
A recently published study investigated the transcriptome of
adult schistosomes following stimulation with hTGFb using the
same microarray platform [27]. The comparison of the differential
transcription of genes upon hTGFb (g 381 genes) or TRIKI-
treatment (g 1766) revealed 77 genes present in both analyses, of
which 58 were regulated in the opposite direction (listed in
Supplementary Table S12; Supplementary Figure S3). The higher
overall number of differentially transcribed genes of the inhibitor
treatment is probably caused by a lower stringency criterion in our
study compared to the study of Oliveira et al. [27], in which only
genes with a log2ratio value $|1| were analyzed. Finally, hTGFb
but not BMP7 was shown to be able to bind SmTbRI [26].
Assuming that hTGFb is not able to activate other type I receptors
of the TGFb superfamily, which is indirectly supported by the
Figure 8. In situ hybridization localizing the schistosome homologs of hippocalcin, ORAI-1, a predicted egg-shell precursor protein
gene, and calmodulin-4. Sections (5 mm) of adult schistosome couples (males and females are indicated), were hybridized with DIG-labeled
antisense-RNA probes of hippocalcin (A, B), ORAI-1 (D, E), eggshell precursor protein gene (G, H), and calmodulin-4 (J, K). For control, DIG-labeled
sense-RNAs probes of hippocalcin (C), ORAI-1 (F), eggshell precursor protein gene (I), and calmodulin-4 (L) were used. Signals were observed in the
ovary (o), the vitellarium (v), around the ootype (ot) where Mehli’s gland is located, and the testes (t). Scale bar: 20 mm.
doi:10.1371/journal.ppat.1003448.g008
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identification of the ligands SmBMP [71] and SmInAct [13], the
response may be specific leading to a narrow response window.
Although previous experiments had shown that TRIKI acts
specifically in comparison with others inhibitors (like those of the
BMP pathway; [72]), it is nonetheless able to inhibit also TGF-b
RII, p38 MAPK, or mixed lineage kinase-7 [73,74]. Since only
homologs of TGFb RII and p38 MAPK exist in S. mansoni, and
since inhibiting these would require 10–15 times higher TRIKI
concentrations, we expected no alternate target effects. However,
we cannot exclude effects on yet unknown targets in schistosomes.
Of the 77 genes present in both analyses, 19 genes showed the
same regulation pattern. This could be explained by the different
sources of RNA used in both studies; whereas in our study RNA of
paired females was used, RNA obtained from parasite couples was
used in the other study [27]. Since the TGFb pathway may fulfil
different functions in both genders, the regulation of transcription
affected by stimulation with hTGFb can be expected to be
different between and within the genders. This could lead to a bias
in the transcriptome analyses, which would not be present if both
analyses were done with RNA obtained from the same source, e.g.
paired females only. Nevertheless, by comparing differentially
transcribed genes detected in both treatments, the majority (75%)
of genes were found to be affected in the opposite direction, which
is in line with the expected outcome of these inversely correlating
approaches (correlation of rs =20,259) (Supplementary Figure
S3). The analysis indicated that more genes were transcriptionally
repressed than enhanced by hTGFb, while more genes were
enhanced than repressed by TRIKI such as the eggshell protein
gene similar to fs800 (Smp_000270; [39]). Herb A-treatment
influenced the transcription of different members of the schisto-
some TGFb pathway, although not all were significant as defined
by our criteria. The homolog of the SmActRIIb belonging to the
TGFb superfamily as well as the SmSmad4 homolog showed the
same regulation as observed by TRIKI-treatment (for both
homologs a significant influence on the transcription was
detected). With respect to the hypothesised pathway cooperation,
these findings supportively complement the TRIKI data. Addi-
tional support for pathway cooperation was obtained by the Y2H
approach identifying SmTK3-interacting molecules, which besides
SmBAF60 and SmDia identified a Smad 2/3 homolog as binding
partner [51]. SRC/Smad binding during TGFb-cooperative
pathway activities was also found in other cellular systems [75].
The importance of both pathways for egg production in
schistosomes was finally confirmed by qPCR experiments focusing
on the question whether genes with proven and hypothesised
functions for egg formation are influenced in their transcription by
these inhibitors. This analysis also included genes from the
microarray analysis not high-lighted as significant according to our
criteria, such as Smp14. Nonetheless, the qPCR results confirmed
enhanced transcription of all genes following TRIKI-treatment,
supporting the evidence of a negative influence of the TGFb
pathway on transcription of these genes. This finding was not
expected due to the results of a former study, which indicated a
slight decrease of egg production upon TRIKI-treatment [11].
However, eggshell formation is a highly complex process and
depends on many genes, of which some -yet unknown and/or not
represented by this analysis- may be negatively affected by TRIKI-
treatment leading to the observed slight decrease in egg numbers.
The complexity of egg production-associated processes was also
demonstrated by a recent study, in which a direct link between egg
production and the mitochondrial oxygen consumption was
presented [76]. One of the crucial steps during this process seems
to be fatty acid b-oxidation, which is initially catalysed within the
mitochondria by acyl CoA dehydrogenase (SmACAD). Within the
microarray data obtained for Herb A-treatment, SmACAD
transcription was significantly repressed. Since the decreased
SmACAD activity was shown to be associated with a decrease of
egg production [76], and since SmACAD transcription was
negatively influenced by Herb A, we conclude that this gene is also
under the control of (a) Src kinase pathway(s). Furthermore, Herb
A treatment led to a strong negative effect on the transcription of
the genes involved in eggshell formation, which perfectly
correlated to the previous finding of a remarkably reduced
number of eggs after treatment with this inhibitor. Although the
decrease of Smp14 transcription was in contrast to Northern blot
data from an elder study [29], which may have been caused by
biological (batch) variation, the more sensitive qPCR data
obtained here corresponded to the microarray data. Furthermore,
all other analyzed genes exhibited the same tendency of
transcription regulation. This was also observed following the
combined inhibitor treatment. Here, down-regulation of all
studied genes was detected, however, it was not as strong as
determined for worms treated exclusively with Herb A. From this
we conclude that the transcriptional values determined for the
combined inhibitor treatment represent an average of the values of
both single-inhibitor treatment approaches, which revealed
contrary transcription values with a bias towards the Herb A
effect. This supports the view of cooperating pathways, but
suggests opposing effects of SmTbRI and Src kinase pathways
regulating egg production in a balanced way. Concerning the
investigated eggshell-forming genes, the influence of both path-
ways was not equal, since the effect of Herb A dominated that of
TRIKI (Fig. 9), which corresponded of the physiological data
obtained previously [11]. Although not directly compared in one
qPCR experiment, the same tendency was also observed for
calmodulin-4 transcription upon treatment with Herb A (strong
up-regulation), or TRIKI (weak down-regulation), or both
inhibitors (up-regulation). Thus calmodulin-4 may represent
another target molecule of the cooperative pathway activity.
Figure 9. Visual model of the inhibitor effects on transcription
of genes involved in eggshell-formation. The inhibition of Src
kinases targeted by Herb A and TbRI by TRIKI revealed an influence of
both inhibitors on the transcription of genes known to play roles in
eggshell formation such as Smp14, Smp48, eggshell precursor protein,
SmTYR1 and fs800. Compared to TRIKI treatment, however, a stronger
effect on transcription was observed when adult schistosome couples
were treated with Herb A. From this we conclude cooperative signal-
transduction activities during eggshell-formation with a more dominant
role of Src kinases in promoting the expression of involved genes.
doi:10.1371/journal.ppat.1003448.g009
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The findings presented in this study extend our knowledge on
mechanisms controlling reproduction in schistosomes, which is an
important, but not yet understood process against the background
of understanding basic principles leading to female maturation and
egg production in schistosomes and other trematodes. For the first
time it is shown that the cooperative actions of TbRI and Src
kinase-containing pathways are involved in the control of egg
formation, a process not only essential for schistosome life-cycling,
but also for the pathological consequences of the disease. In light
of the necessity to find alternatives to Praziquantel, the only drug
applied worldwide to fight schistosomiasis [77], our findings may
also open novel perspectives for alternative concepts to interfere
with the transmission of schistosomes by negatively influencing egg
production thus interrupting the parasite life cycle. Here kinases
have already suggested their potential as targets by in vitro
experiments [78].
Materials and Methods
Parasite stock
A Liberian isolate of Schistosoma mansoni was maintained in the
intermediate host Biomphalaria glabrata, and Syrian hamsters
(Mesocricetus auratus) as final host [79,80]. 42 days post infection
adult worms were obtained by hepatoportal perfusion.
All animal experiments have been done in accordance with the
European Convention for the Protection of Vertebrate Animals
used for experimental and other scientific purposes (ETS No 123;
revised Appendix A) and have been approved by the Regional
Council (Regierungspraesidium) Giessen (V54-19 c 20/15 c GI
18/10).
In vitro-culture and inhibitor treatment of adult
schistosomes
After perfusion with M199 medium (Gibco; including glucose,
sodium bicarbonate, 4-(2-hydroxyethyl)-1-piperazineethane sulfon-
ic acid), the worms were washed twice with this medium and
subsequently cultured in M199 supplemented with FCS (Gibco;
10%), HEPES (Sigma; 1M, 1%), and antibiotic/antimycotic
mixture (Sigma; 1%) at 37uC and 5% CO2, as described previously
[33]. For inhibitor treatments, worm couples were left in culture for
2 days adapting to the in vitro environment to restore full egg
production capacity [11,29]. Both Herbimycin A (Herb A, Enzo
Life Science; CAS: 70563-58-5; 1 mg/ml) and the TbRI kinase
inhibitor (TRIKI, or LY-364947; purchased from Calbiochem;
CAS: 396129-53-6; 5 mg/ml) were dissolved in dimethyl sulfoxide
(DMSO). TRIKI (C17H12N4) is a pyrazole-based inhibitor (3-
(pyridin-2-yl)-4-(4-quinonyl)-1H-pyrazole) with an IC50 value of
51 nM for human TbRI (Calbiochem; [73,74]). It binds to the
active site of the TbRI kinase domain and is less effective inhibiting
TGF-b RII (IC50= 400 nM), p38 MAPK (IC50= 740 nM), or
mixed lineage kinase-7 (MLK-7; IC50= 1,400 nM).
For transcriptome studies the cultivation of adult schistosomes
was done for 2 days with either 4.5 mM Herb A, 300 nM TRIKI,
or the combination of both inhibitors (H+T) with the same
concentrations. As control, worms were cultivated in medium
containing DMSO. Medium and additives were refreshed daily.
Pairing stability and vitality were checked each day. As vital and
useful for further experiments we considered couples, whose males
sucked with their ventral suckers to the Petri dish, while keeping
the female within the gynaecophoric canal. Vital worms
performed uniform, wave-like movements, showed regular gut
peristaltic, and produced eggs. Separation of couples and/or
failing of males to suck to the Petri dish, resting on the side and
showing reduced wave-like movements were considered as signs of
decreasing vitality. Such worms were removed from the dishes and
not considered for further analyses.
Worms used for the experiments (treated and control samples
likewise) were carefully separated by pipetting or using feather-
weight tweezers, immediately shock-frozen in liquid nitrogen, and
stored at 280uC for further use.
GVBD assays in Xenopus oocytes
To test whether TRIKI was able to inhibit SmTbRI
(Smp_049760), its intracellular part was cloned into the expression
vector pcDNA 3.1/V5-His B. To this end this region was
amplified by PCR with cDNA as template and the primers
TGFbRI_intra_BamHI-59 (59-GGATCCTACTTCCTCTGGA-
GAAGGAAATC-39) and TGFbRI_intra_EcoRV-39 (59-GA-
TATCTAAATGCTTTGAATTACTATTGTTATTGG-39).
Both primers contained specific restriction sites (59 primer BamHI;
39 primer EcoRV), which were used for directed cloning of the
amplification product into the vector. The obtained wild type (wt)
SmTbRI-pcDNA 3.1/V5-His construct was commercially se-
quenced (LGC Genomics, Berlin) to confirm the correct open
reading frame (ORF). To convert wt SmTbRI into a constitutively
active variant, the Ser and Thr residues of the GS motif (position
284–290) as well as the Thr (position 299) and Gln (position 303)
were mutated into 7 Asp (SmTbRI7D) as described earlier [35].
For negative control, an inactive kinase variant was generated by
exchanging Thr residues to Val, as well as by exchanging Ser and
Gln residues to Ala (SmTbRIVVAAAVV). These mutations were
done successively by site-directed mutagenesis, using the SmTbRI-
pcDNA 3.1/V5-His wt construct as template (25 ng) and the
following primers: TGFbRI_Mut-1(5D)-59 (59-GATGGACCAC-
GATGACGATGGGGACGGTGACGGAAAACCTTTACT-39)
+ TGFbRI_Mut-1(5D)-39 (59-AGTAAAGGTTTTCCGTCACC-
GTCCCCATCGTCATCGTGGTCCATC-39); TGFbRI_Mut-
2(7D)-59 (59-CCTTTACTAGTTCAGCGAGATGTCGCTAG-
GGACGTTCAGTTGG-39) + TGFbRI_Mut-2(7D)-39 (59-CCA-
ACTGAACGTCCCTAGCGACATCTCGCTGAACTAGTAA-
AGG-39); TGFbRI_Mut-1(VVAAA)-59 (59-GATGGACCACGT-
TGTCGCTGGGGCAGGTGCCGGAAAACCTT-39) + TGF-
bRI_Mut-1(VVAAA)-39 (59-AAGGTTTTCCGGCACCTGCC-
CCAGCGACAACGTGGTCCATC-39); TGFbRI_Mut-2(VV)-
59 (59-CCTTTACTAGTTCAGCGAGTGGTCGCTAGGGTA-
GTTCAGTTGG-39) + TGFbRI_Mut-2(VV)-39 (59-CCAAC-
TGAACTACCCTAGCGACCACTCGCTGAACTAGTAAAG-
G-39). For PCR the proofreading Pfu DNA-Polymerase (Promega;
3 U/ml) was used followed by DpnI digestion for 1 h at 37uC to
digest remaining wt vector DNA [81]. Following bacteria
transformation and plasmid-DNA isolation, sequencing confirmed
the correct ORFs of the constructs. Subsequently, cRNA synthesis
was done as previously described [32], and 60 ng each used for
microinjection into Xenopus laevis stage VI oocytes [31,32]. The
oocytes were cultured in ND96 medium at 19uC for 18 h.
Germinal vesicle break down (GBVD), a witness of meiosis
progression dependent on kinase activity [30], is characterized by
the development of a white spot at the animal pole of the oocyte.
As a positive control for GVBD, oocytes were stimulated with
progesterone. As negative controls, non-injected oocytes as well as
oocytes transfected with the inactive kinase variant SmTbRIV-
VAAAVV were used. For inhibitor studies, oocytes were cultured in
ND96 medium supplemented with different concentrations of
TRIKI (3 nM, 30 nM, and 300 nM) for 18 h.
RNA extraction and microarray experiments
RNA from inhibitor-treated or from control females was
isolated using Trizol reagent (Invitrogen). Subsequently, a DNAse
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digestion was done with the RNAeasy kit (Qiagen) according to
the manufacturer’s manual. The quality of the isolated RNA was
determined using Bioanalyzer microfluidic electrophoresis (Agilent
Technologies).
For microarray experiments a S. mansoni custom-designed
oligonucleotide platform (60-mers) was used, with approximately
44,000 probes representing nearly the complete S. mansoni
transcriptome based on available cDNA sequence data from S.
mansoni and S. japonicum. This platform was produced by Agilent
Technologies (described in [36], and all associated information
(probes, annotation) is available at Gene Expression Omnibus
(GEO) under the accession number GPL8606.
From each sample of the three inhibitor treatments, 300 ng
RNA were used for cDNA amplification followed by Cy3 and Cy5
labelling during in vitro transcription using the Quick Amp
Labelling Kit, two colors (Agilent Technologies). Labelling
included a dye-swap approach as an internal technical replica
for each sample. Thus, six microarray hybridizations were
performed per inhibitor treatment and corresponding controls,
including two technical replicas for each of the three biological
replicas. For hybridization, 825 ng cRNA of each labelled
inhibitor sample were used and combined with a control sample
labelled with the opposite dye.
Hybridization was done at 65uC for 17 h with rotation. The
slides were washed and scanned with the Gene Pix 4000B Scanner
(Molecular Devices) according to the Agilent manual. The
obtained raw data were extracted using Feature Extraction
software (Agilent Technologies) and are available under GEO
study number GSE39732. For subsequent analyses, a gene was
considered as expressed only if its corresponding probe exhibited
signals that were significantly higher than background (employing
default parameters from the Feature Extraction software and
recovering the column ‘‘IsPosAndSig’’ from the output). A probe
had to fulfil the criterion to have detectable expression in at least
75% of all replicas in at least one of the two conditions (inhibitor-
treated or control). LOWESS algorithm was used for normalisa-
tion of the intensities [82], and the log2ratios between inhibitor-
treated and control groups were calculated. Subsequently, an
adjustment of these filtered data was done using an updated
genome annotation to eliminate redundancy of the probes per
gene [37]. A low overall correlation was observed for the technical
replicates Herb/DMSO 4 and H+T/DMSO 1, leading to the
exclusion of these experiments from further analyses. As a
consequence, the technical replicate TRIKI/DMSO 4 treatment
was removed additionally to achieve a comparable basis for the
analysis of all three microarray approaches; the latter technical
replicate was selected for exclusion based on its lowest total
intensities of the fluorescence signals.
To identify genes with a significant change in the levels of
transcribed message, SAM (Significance Analysis of Microarrays)
was used [83]; genes with a q-value#0.03 were considered to have
a significantly differential level of transcribed message between
inhibitor-treated and control samples. The subsequent functional
analyses focused on probes representing protein-coding genes
(labelled as ‘‘to be used in GO=YES’’ in the updated annotation
of the array [37]), although antisense-oriented oligonucleotide
probes were present on the microarray platform as well.
Hierarchical clustering was done using Spotfire [84]. Functional
analyses were performed for differentially transcribed genes; Gene
Ontology (GO) analyses [85] of all three inhibitor data sets were
done with the software tool Ontologizer [86]; parent child union
[87] was selected to identify categories containing enriched genes,
and the p-value was adjusted according to Benjamini-Hochberg
(BH) correction [88]. Further functional analyses were performed
by Ingenuity Pathway Analysis (IPA; http://www.ingenuity.com;
[89]), which represents a tool providing curated information from
the literature for human, mouse and rat models about canonical
pathways, regulated transcription factors and their targets, and
possibly regulated molecular networks, including signal transduc-
tion cascades (of which some contribute to human cancer and
other diseases). To this end, all S. mansoni genes were annotated
with the corresponding human homolog (determined according to
a search with the following blast parameters: e-value,10210 and
at least 60% coverage); genes that fulfilled these criteria were
annotated with the label ‘‘to be used in IPA=YES’’ in the updated
annotation [37], and they were uploaded to IPA along with their
corresponding microarray transcription measurements. These
putative homologs represented the basis for the identification of
pathways and networks enriched with proteins encoded by
significantly differentially transcribed genes; default settings were
used, except for presentation of networks (140 molecules per
network, number of networks: 10) and for ‘‘user dataset’’ as
reference set.
Quantitative PCR experiments
To validate the transcriptional changes caused by inhibitor
treatment of selected genes quantitative PCRs (qPCRs) were
performed on a Rotor Gene Q (Qiagen). RNAs from inhibitor-
treated or control females were isolated using TriFast reagent
(PeqLab), and 1 mg each was reverse transcribed using QuantiTect
Rev. Transcription kit (Qiagen) according to the manufacturer’s
instruction. The amplified cDNA was diluted 1:20 and used for
subsequent qPCR analyses. The detection of synthesised DNA
double strands was based on the incorporation of SYBRGreen
using PerfeCTa SYBR Green Super Mix (Quanta). To distinguish
between the specific amplification product and unspecific primer
dimers following each qPCR analysis a melting point analysis was
done. Primer 3 Plus software was used for primer design (http://
www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi).
The amplification products had a size between 140 and 160 bases.
Primers were designed to have melting points at 60uC.
Furthermore, differentiation of amplification products of cDNA
and genomic DNA was obtained by designing primers that flanked
predicted introns of the appropriate genes. A list of all used
primers is available in Supplementary Table S13. All primers were
commercially synthesised by Biolegio (Netherlands).
Since standard reference genes normally used for relative
quantification analyses such as a-tubulin, Cu/Zn SOD (superox-
ide dismutase), or histone showed regulation following inhibitor
treatment, we decided to perform absolute quantification on the
basis of standard curves generated by purified PCR products (used
in dilution series) [90]. These quantifications were done for both
inhibitor- and DMSO-treated samples. Fold changes are available
in Supplementary Tables S2, S5, and S8. Subsequently, log2ratios
(treated/control) were calculated according to a previous study
providing a solid basis for comparison of microarray and qPCR
data [91]. The efficiency of each qPCR was determined to be
between 90–100%. Finally, the validity of the obtained ratios of
qPCRs and microarrays was determined by Spearman’s rank
correlation coefficient (rs) as well as the correlation of the
intersection of the microarray data following hTGFb and
TRIKI-treatment [92,93].
In situ hybridization experiments
To detect the occurrence of transcripts of ORAI-1, hippocalcin,
the predicted eggshell precursor protein gene, and calmodulin-4 of
S. mansoni, in situ hybridizations were performed as described
earlier [33,51]. To this end, adult worm pairs were fixed in Bouin’s
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solution (picric acid/acetic acid/formaldehyde; 15/1/5) and
embedded in paraplast (Histowax, Reichert-Jung) before sections
of 5 mm were generated and incubated in xylol. Following re-
hydration, proteins were removed by proteinase K treatment
(freshly prepared, final concentration 1 mg/ml), and the sections
were dehydrated. For hybridization, transcripts were generated in
vitro by RT-PCR, checked for their identity by sequencing, and
labeled with digoxigenin following the manufacturers’ instructions
(Roche). The following primer combinations were used for
amplification (hippocalcin, Smp_085650: forward 59-GCTATT-
TATGCGATGGTTGGC-39, reverse 59-GACTCTGAGGTAT-
CAGGAATGAC-39; ORAI-1, Smp_076650.1: forward 59-GT-
TGTCGTGCATATAATGGCT-39, reverse 59-CTGGACTC-
CACTTCTAAGAAAGG-39; eggshell precursor protein gene,
Smp_000430: forward 59-GTTCCAATTACCAACCAACGTC-
39, reverse 59-GTTTCCGTTACCACCATAATTACC-39; cal-
modulin-4, Smp_032990: forward 59-ATGAATGTTCCAATAA-
CTCGTGAAG-39, reverse 59-AAGTGCTCTTGTTAATTC-
TGGTAAAC-39). Primers were 59-tagged by the addition of the
T7-sequence (59-TAATACGACTCACTATAGGGAGA-39) to
allow RT-PCR-based product synthesis of antisense or sense
probes using T7 polymerase (Roche). PCR conditions to amplify
calmodulin-4 were: denaturation 95uC 45 s, annealing 56uC 45 s,
elongation 72uC 45 s; 30 cycles; for all other transcripts:
denaturation 95uC 45 s, annealing 60uC 45 s, elongation 72uC
30 s; 30 cycles. Labeled transcripts of hippocalcin (359 bp),
ORAI-1 (428 bp), the hypothesized eggshell precursor protein
gene (533 bp), and calmodulin (210 bp) were size-controlled by gel
electrophoresis. To prove their quality, transcript blots were made
confirming digoxigenin-incorporation by alkaline phosphatase-
conjugated anti-digoxigenin antibodies (Roche) with naphthol-AS-
phosphate and Fast Red TR (Sigma). All in situ hybridizations were
performed for 16 h at 42uC. Sections were washed up to 16SSC,
and detection was achieved as described for transcript blots.
RT-PCR with organ-specific RNA
Testes and ovaries were isolated by a recently established organ-
isolation method [Hahnel et al., submitted]. In short, adult males
or females (50–60 each) were treated with 500 ml of tegument
solubilisation (TS)-buffer (0.5 g Brij35, 0.5 g Nonidet P40, 0.5 g
Tween80, and 0.5 g TritonX-405 per 100 ml PBS (137 mM
NaCl, 2.6 mM KCl, 10 mM Na2HPO4, 1.5 mM KH2PO4 in
DEPC-H2O, pH 7.2–7.4)) at 37uC and 1,200 rpm in a shaker for
5 min to solubilise the tegument. This step was repeated for
females (16) and males (26) followed by washing steps (36) with
M199 medium (2 ml). To remove the muscles, elastase IV from
pancreas (Sigma, #E0258) was used (5 units/ml, in M199
medium), and 500 ml added to each sample followed by slight
agitation (600 rpm) in a shaker at 37uC for about 30 min. During
incubation, the worms were swirled up manually every 5 min.
This reaction was stopped when the medium turned opaque and
the worms were fragmented but not completely digested. At this
point liberated intact organs were observed. Testes and ovaries
were identified by their characteristic morphology and carefully
transferred by pipetting to fresh M199 medium. For quality
inspection bright field microscopy was performed and if necessary,
the organs were separated from remaining tissue rests by
additional washes and transfers. Finally, the organs were collected
by a pipette, transferred to 1.5 ml tubes, and concentrated by
centrifugation for 5 min at 1,000 g (testes) or 1 min at 8,000 g
(ovaries). After removal of the supernatant the organs were frozen
in liquid nitrogen and stored at 280uC for further use.
For cDNA synthesis the QuantiTect Reverse Transcription Kit
(Qiagen) was used with 500 ng of total RNA as template following
the instruction of the manufacturer. PCR was done with 2 ml of a
1:40-dilution (testis cDNA) or 1:80-dilution (ovary cDNA) of each
cDNA-sample in a total volume of 50 ml containing 16 reaction
buffer (80 mM Tris-HCl, 20 mM (NH4)2SO4, 0.02% w/v
Tween20, 2.5 mM MgCl2), 200 mM dNTPs, 400 nM of each
primer and 2.5 units Fire-Pol taq polymerase (Solis BioDyne). The
reactions were performed in a MasterCycler (Eppendorf) pro-
grammed as follows: 1 cycle, 95uC, 2 min; 35 cycles, 95uC, 45 sec;
60uC, 45 sec; 72uC, 45 sec. The primers used to amplify
hippocalcin, eggshell precursor protein gene, and calmodulin-4
were mentioned above, primers used for ORAI-1 amplification
were newly designed to be able to detect both splice variants of this
gene (Smp_076650.1, Smp_076650.2; forward 59- ACGTTGT-
TACTTCTTCAGTACTCC-39; reverse 59-ACTTTGTAGG-
TAGTAAGCGCAC-39). As positive control for similar amounts
of cDNA of each organ-sample the S. mansoni heat shock protein
70 gene (SmHSP70 accession number L02415; forward 59-
TGGTACTCCTCAGATTGAGGT-39; reverse 59-ACCTTCT-
CCAACTCCTCCC-39) was used since as it was described to be
expressed throughout diverse life stages and tissues, and it turned
out to be a suitable control [94; Hahnel et al., submitted].
In silico analysis
The following public domain tools were used: SchistoDB
(http://schistodb.net/schisto/), Gene DB (http://www.genedb.
org/Homepage), Welcome Trust Sanger Institute S. mansoni
OmniBlast (http://www.sanger.ac.uk/cgi-bin/blast/submitblast/
s_mansoni/omni), BLAST (http://blast.ncbi.nlm.nih.gov/), Clus-
tal W2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/), InterPro
(http://www.ebi.ac.uk), SMART (http://smart.embl-heidelberg.
de/).
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Supporting Information
Figure S1 Network 3 of the IPA analysis following
Herbimycin A-treatment (q#0.03). Example of an IPA-
based network (no. 3) presenting proteins coded by differentially
transcribed genes following Herb A-treatment. These molecules
are involved in RNA post-transcriptional modification, DNA
replication, recombination as well as repair and energy produc-
tion. The shapes of the genes correlate with the functional
classification symbolised in the legend. A= entire network.
B= close up of the framed area in A (square). Arrows represent
the relationship between molecules: dashed lines = indirect
interaction, continuous lines = direct interaction; color intensity
correlates to transcription value, calculated as log2ratio (treated/
control) in Herb A-treated paired females; green represents
molecules with repressed transcription (negative log2ratio); red
represents molecules with enhanced transcription (positive log2-
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ratio); grey represents molecules present in the dataset, but did not
meet the defined cut-off for differential transcription; white
represent molecules, which were included in the network because
of their known relationships with other detected molecules, but
they were not present within the data set.
(TIF)
Figure S2 RT-PCR with organ-specific RNA confirmed
and complemented in situ-hybridization data. Shown are
RT-PCR results with organ-specific RNA of purified testes (lanes
1, 3, 5, 7, 9) and ovaries (lanes 2, 4, 6, 8, 10) indicating the
presence of transcripts of hippocalcin (lanes 1, 2), ORAI-1 (lanes 3,
4), the egg-shell precursor gene (lanes 5, 6), and calmodulin-4
(lanes 7, 8). As positive control hsp70 was used (lanes 9, 10), which
was shown to be widely expressed [94] serving as a suitable control
also for gonad tissue [Hahnel et al., submitted]. The two bands in
lanes 3 and 4 resulted from two different splice forms of ORAI-1
(Smp_076650.1, Smp_076650.2; expected products 491 bp and
532 bp), which were detected both by the used primers. M:
HyperLadder (Bioline).
(TIF)
Figure S3 Comparison of differentially transcribed
genes following hTGFb- or TRIKI-treatment. Hierarchical
clustering of genes differentially transcribed after either hTGFb
stimulation [27] or TRIKI-induced inhibition of female schisto-
somes. Each line represents one of 77 genes that were identified to
be differentially transcribed in both microarray analyses. The
comparison was done using the mean log2ratio (treated/control) of
transcription of these genes; genes with an enhanced transcription
in treated compared to control are shown in red, and with a
repressed transcription in green.
(TIF)
Table S1 List of the numbers of significantly differen-
tially transcribed genes following inhibitor treatments
(q#0.03). This table contains a list of the numbers of significantly
differentially transcribed genes following inhibitor treatments
(q#0.03).
(DOCX)
Table S2 List of genes found to be significantly
differentially transcribed following TRIKI-treatment.
This list contains all information about genes found to be
significantly differentially transcribed following TRIKI-treatment
(including subdivisions of up- and down-regulated sense and
antisense transcripts).
(XLSX)
Table S3 Gene Ontology categories enriched with
differentially transcribed genes following TRIKI-treat-
ment. Gene Ontology categories are listed enriched with
differentially transcribed genes following TRIKI-treatment (in-
cluding up- and down-regulated categories).
(XLSX)
Table S4 Networks of enriched molecules identified by
IPA using the data set of differentially transcribed genes
following TRIKI-treatment. This is a list of networks of
enriched molecules identified by Ingenuity Pathway Analysis (IPA)
of genes differentially transcribed following TRIKI-treatment.
(XLSX)
Table S5 List of genes found to be significantly
differentially transcribed following Herbimycin A-treat-
ment. This list contains all information on genes found to be
significantly differentially transcribed following Herbimycin A-
treatment (including subdivisions of up- and down-regulated sense
and antisense transcripts).
(XLSX)
Table S6 Gene Ontology categories enriched with
significantly differentially transcribed genes following
Herbimycin A-treatment. Gene Ontology categories are listed
enriched with differentially transcribed genes following Herbimy-
cin A-treatment (including up-regulated categories).
(XLSX)
Table S7 Networks of enriched molecules identified by
IPA using the data set of differentially transcribed genes
following Herbimycin A-treatment. This is a list of networks
of enriched molecules identified by Ingenuity Pathway Analysis
(IPA) of genes differentially transcribed following Herbimycin A-
treatment.
(XLSX)
Table S8 List of genes found to be significantly
differentially transcribed following combined treat-
ment with Herbimycin A and TRIKI. This list contains
genes found to be significantly differentially transcribed following
combined treatment with Herbimycin A and TRIKI (including
subdivisions of up- and down-regulated sense and antisense
transcripts).
(XLSX)
Table S9 Gene Ontology categories enriched with
significantly differentially transcribed genes following
combined treatment with TRIKI and Herbimycin A.
Gene Ontology categories are listed enriched with differentially
transcribed genes following combined TRIKI and Herbimycin A-
treatment (including up-regulated categories).
(XLSX)
Table S10 Networks of enriched molecules identified by
IPA using the data set of differentially transcribed genes
following combined treatment with TRIKI and Herbi-
mycin A. This is a list of networks of enriched molecules
identified by Ingenuity Pathway Analysis (IPA) of genes differen-
tially transcribed following combined TRIKI and Herbimycin A-
treatment.
(XLSX)
Table S11 Intersections of genes differentially tran-
scribed following treatment with TRIKI and Herbimycin
A. This list contains all intersections from the single as well as the
combined treatments with TRIKI and/or Herbimycin A (4
subdivisions).
(XLSX)
Table S12 Intersection of significantly differentially
transcribed genes following hTGFb stimulation and
TRIKI-treatment. This list contains the intersection of
significantly differentially transcribed genes following hTGFb
stimulation and TRIKI-treatment subdivided in ‘‘overlap’’,
‘‘different regulation’’, and ‘‘same regulation’’ categories.
(XLSX)
Table S13 List of primers used for qPCR.
(DOCX)
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